hydroxyurea has been researched along with Oropharyngeal Neoplasms in 2 studies
Oropharyngeal Neoplasms: Tumors or cancer of the OROPHARYNX.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A consecutive sample of 29 patients with advanced oropharyngeal or hypopharyngeal cancer who were treated with intravenous hydroxyurea and concomitant hyperfractionated, accelerated radiotherapy." | 5.11 | Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma. ( Beitler, JJ; Goldman, SY; Smith, RV; Wadler, SS, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, RV | 1 |
| Goldman, SY | 1 |
| Beitler, JJ | 1 |
| Wadler, SS | 1 |
| Fountzilas, G | 1 |
| Daniilidis, J | 1 |
| Kosmidis, P | 1 |
| Sridhar, KS | 1 |
| Kalogera-Fountzila, A | 1 |
| Banis, K | 1 |
| Avramidis, V | 1 |
| Tsavdaridis, D | 1 |
| Themelis, C | 1 |
| Zaramboukas, T | 1 |
1 trial available for hydroxyurea and Oropharyngeal Neoplasms
| Article | Year |
|---|---|
Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Deglutition Disorders; Dose Fractiona | 2004 |
1 other study available for hydroxyurea and Oropharyngeal Neoplasms
| Article | Year |
|---|---|
Platinum-based induction chemotherapy followed by radiation as definitive treatment for patients with locally advanced cancer of the oral cavity, oropharynx and hypopharynx. A retrospective analysis of 32 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; | 1991 |